Login
Home
Charts
Search
Watchlist
Products

Kobo Biotech Ltd

KOBO·BSE
₹4.13-1.90%Tue, 22 Sept '26
Industry:Pharmaceuticals Bulk Drugs & Formulation
Indices:

Kobo Biotech Ltd

KOBO
BSE
₹4.13
-1.90%
|Tue, 22 Sept '26
SOICxStockScans Reports
Industry
Pharmaceuticals Bulk Drugs & Formulation
Indices
View
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹10Cr
Close
Close Price
₹4.13
Industry
Industry
Pharmaceuticals Bulk Drugs & Formulation
PE
Price To Earnings
—
PS
Price To Sales
—
Revenue
Revenue
₹0Cr
Rev Gr TTM
Revenue Growth TTM
—
PAT Gr TTM
PAT Growth TTM
1.51%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterSep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
Revenue
RevenueCr
000000000000
Growth YoY
Revenue Growth YoY%
Expenses
ExpensesCr
109000100000
Operating Profit
Operating ProfitCr
-10-9000-100000
OPM
OPM%
Other Income
Other IncomeCr
000000000000
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
111111111111
PBT
PBTCr
-2-1-10-1-1-1-2-1-1-1-1-1
Tax
TaxCr
000000000000
PAT
PATCr
-2-1-10-1-1-1-2-1-1-1-1-1
Growth YoY
PAT Growth YoY%
67.376.5-375.88.140.911.882.816.3-10.9-3.429.6-8.1
NPM
NPM%
EPS
EPS₹
-0.8-0.6-4.4-0.6-0.5-0.5-0.8-0.5-0.5-0.5-0.5-0.6
QuarterSep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
Revenue
RevenueCr
000000000000
Growth YoY
Revenue Growth YoY%
Expenses
ExpensesCr
109000100000
Operating Profit
Operating ProfitCr
-10-9000-100000
OPM
OPM%
Other Income
Other IncomeCr
000000000000
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
111111111111
PBT
PBTCr
-2-1-10-1-1-1-2-1-1-1-1-1
Tax
TaxCr
000000000000
PAT
PATCr
-2-1-10-1-1-1-2-1-1-1-1-1
Growth YoY
PAT Growth YoY%
67.376.5-375.88.140.911.882.816.3-10.9-3.429.6-8.1
NPM
NPM%
EPS
EPS₹
-0.8-0.6-4.4-0.6-0.5-0.5-0.8-0.5-0.5-0.5-0.5-0.6

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Revenue
RevenueCr
572933000000000
Growth
Revenue Growth%
-48.912.0-100.0
Expenses
ExpensesCr
6139284321311211
Operating Profit
Operating ProfitCr
-4-95-4-3-2-1-3-11-2-1-1
OPM
OPM%
-7.8-32.514.8
Other Income
Other IncomeCr
03060-2000000
Interest Expense
Interest ExpenseCr
18161414151414110000
Depreciation
DepreciationCr
1087766665444
PBT
PBTCr
-32-30-16-19-24-24-21-19-15-6-5-5
Tax
TaxCr
100000000000
PAT
PATCr
-33-30-16-19-24-24-21-19-15-6-5-5
Growth
PAT Growth%
7.145.6-16.9-24.4-2.214.18.420.863.511.3-6.1
NPM
NPM%
-57.3-104.1-50.6
EPS
EPS₹
-14.5-13.4-6.9-8.1-10.0-10.3-8.8-8.1-6.4-2.3-2.1-2.2
Financial YearMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Revenue
RevenueCr
572933000000000
Growth
Revenue Growth%
-48.912.0-100.0
Expenses
ExpensesCr
6139284321311211
Operating Profit
Operating ProfitCr
-4-95-4-3-2-1-3-11-2-1-1
OPM
OPM%
-7.8-32.514.8
Other Income
Other IncomeCr
03060-2000000
Interest Expense
Interest ExpenseCr
18161414151414110000
Depreciation
DepreciationCr
1087766665444
PBT
PBTCr
-32-30-16-19-24-24-21-19-15-6-5-5
Tax
TaxCr
100000000000
PAT
PATCr
-33-30-16-19-24-24-21-19-15-6-5-5
Growth
PAT Growth%
7.145.6-16.9-24.4-2.214.18.420.863.511.3-6.1
NPM
NPM%
-57.3-104.1-50.6
EPS
EPS₹
-14.5-13.4-6.9-8.1-10.0-10.3-8.8-8.1-6.4-2.3-2.1-2.2

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Equity Capital
Equity CapitalCr
232324242424242424242424
Reserves
ReservesCr
22-9-23-42-66-91-112-131-146-152-157-162
Current Liabilities
Current LiabilitiesCr
155164180207242266284299163166168173
Non Current Liabilities
Non Current LiabilitiesCr
797474644740403938373636
Total Liabilities
Total LiabilitiesCr
27925226025224623923623179757172
Current Assets
Current AssetsCr
16114215815715715715915938383842
Non Current Assets
Non Current AssetsCr
118110102958983777142383429
Total Assets
Total AssetsCr
27925226025224623923623179757172
Financial YearMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Equity Capital
Equity CapitalCr
232324242424242424242424
Reserves
ReservesCr
22-9-23-42-66-91-112-131-146-152-157-162
Current Liabilities
Current LiabilitiesCr
155164180207242266284299163166168173
Non Current Liabilities
Non Current LiabilitiesCr
797474644740403938373636
Total Liabilities
Total LiabilitiesCr
27925226025224623923623179757172
Current Assets
Current AssetsCr
16114215815715715715915938383842
Non Current Assets
Non Current AssetsCr
118110102958983777142383429
Total Assets
Total AssetsCr
27925226025224623923623179757172

Cash Flow

Consolidated
Standalone
Financial YearMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating Cash Flow
Operating Cash FlowCr
1119632312114394104
Investing Cash Flow
Investing Cash FlowCr
-5000000025000
Financing Cash Flow
Financing Cash FlowCr
-7-21-5-33-31-21-14-1-120-100
Net Cash Flow
Net Cash FlowCr
-1-1000001-1004
Free Cash Flow
Free Cash FlowCr
6196323121143107104
CFO To PAT
CFO To PAT%
-33.8-63.9-34.1-167.9-131.6-85.6-68.9-13.1-615.8-15.8-4.1-79.8
CFO To EBITDA
CFO To EBITDA%
-247.5-204.3117.0-798.7-1,041.8-1,218.3-2,104.8-90.0-892.8-58.4-23.3-338.3
Financial YearMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating Cash Flow
Operating Cash FlowCr
1119632312114394104
Investing Cash Flow
Investing Cash FlowCr
-5000000025000
Financing Cash Flow
Financing Cash FlowCr
-7-21-5-33-31-21-14-1-120-100
Net Cash Flow
Net Cash FlowCr
-1-1000001-1004
Free Cash Flow
Free Cash FlowCr
6196323121143107104
CFO To PAT
CFO To PAT%
-33.8-63.9-34.1-167.9-131.6-85.6-68.9-13.1-615.8-15.8-4.1-79.8
CFO To EBITDA
CFO To EBITDA%
-247.5-204.3117.0-798.7-1,041.8-1,218.3-2,104.8-90.0-892.8-58.4-23.3-338.3

Ratios

Consolidated
Standalone
Financial YearMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
2061671722117181359810
Price To Earnings
Price To Earnings
Price To Sales
Price To Sales
0.32.12.1
Price To Book
Price To Book
0.44.4166.8-0.9-0.5-0.2-0.1-0.2-0.10.0-0.1-0.1-0.1
EV To EBITDA
EV To EBITDA
-33.1-19.942.0-48.5-65.8-113.6-299.0-99.2-14.6-96.4-170.3-115.7-117.8
Profitability Ratios
Profitability Ratios
GPM
GPM%
6.9-2.729.0
OPM
OPM%
-7.8-32.514.8
NPM
NPM%
-57.3-104.1-50.6
ROCE
ROCE%
-8.0-10.4-1.5-3.0-7.0-8.5-5.9-5.5-82.5-46.8-72.7-337.2-337.2
ROE
ROE%
-73.1-221.3-4,140.9103.556.336.523.917.912.44.33.73.83.8
ROA
ROA%
-11.7-12.0-6.3-7.6-9.7-10.2-8.9-8.3-19.2-7.4-6.9-7.3-7.3
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
2061671722117181359810
Price To Earnings
Price To Earnings
Price To Sales
Price To Sales
0.32.12.1
Price To Book
Price To Book
0.44.4166.8-0.9-0.5-0.2-0.1-0.2-0.10.0-0.1-0.1-0.1
EV To EBITDA
EV To EBITDA
-33.1-19.942.0-48.5-65.8-113.6-299.0-99.2-14.6-96.4-170.3-115.7-117.8
Profitability Ratios
Profitability Ratios
GPM
GPM%
6.9-2.729.0
OPM
OPM%
-7.8-32.514.8
NPM
NPM%
-57.3-104.1-50.6
ROCE
ROCE%
-8.0-10.4-1.5-3.0-7.0-8.5-5.9-5.5-82.5-46.8-72.7-337.2-337.2
ROE
ROE%
-73.1-221.3-4,140.9103.556.336.523.917.912.44.33.73.83.8
ROA
ROA%
-11.7-12.0-6.3-7.6-9.7-10.2-8.9-8.3-19.2-7.4-6.9-7.3-7.3
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios

Documents — Kobo Biotech Ltd

  • Q1 FY2025 Quarterly Result (Jun 2024, PDF): https://www.stockscans.in/document/k73hn8ziwdmq63nn0r4q1y1n.pdf
  • Q4 FY2024 Quarterly Result (Mar 2024, PDF): https://www.stockscans.in/document/zivisd3lxea1f0tlnqqmi17c.pdf
  • Q3 FY2024 Quarterly Result (Dec 2023, PDF): https://www.stockscans.in/document/phaevuft16fvm37tfbumli3c.pdf
  • Q2 FY2024 Quarterly Result (Sep 2023, PDF): https://www.stockscans.in/document/jem5k7rpkfmkzofm8brhpywq.pdf
  • Q1 FY2024 Quarterly Result (Jun 2023, PDF): https://www.stockscans.in/document/jj0qmw1lgetch91qob3wftmk.pdf
  • Q4 FY2023 Quarterly Result (Mar 2023, PDF): https://www.stockscans.in/document/eheokem50feql21elvcd0m9k.pdf
  • Q3 FY2023 Quarterly Result (Dec 2022, PDF): https://www.stockscans.in/document/i7l0vc623olm5v328y0lfy61.pdf
  • Q2 FY2023 Quarterly Result (Sep 2022, PDF): https://www.stockscans.in/document/g1y9xjg2x2jlqw06hdr1f8v0.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/g0xk95q069g7dku757sas4ef.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/skqybphm6xyvbx7bw2dzl5dt.pdf
  • FY2023 Annual Report (PDF): https://www.stockscans.in/document/ekcoovzcjyq7cl3lsaa0u7xf.pdf
  • FY2022 Annual Report (PDF): https://www.stockscans.in/document/czv2p99u1ntf7l7gr5wmx5v4.pdf
  • FY2021 Annual Report (PDF): https://www.stockscans.in/document/4yczginjmbfiyysu7a7tfipj.pdf
  • FY2020 Annual Report (PDF): https://www.stockscans.in/document/chzs0iedjhj9enrpwsjn1lpt.pdf

Simplify stock analysis with powerful tools and clear insights for confident, data-driven decisions.

support@stockscans.in
© StockScans by SOIC Technologies Pvt Ltd
349 A, Lodhi Road, Punjabi Bazar, New DelhiData provided by CMOTS Internet Technologies